Device Trial Radar · NCT07227532
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
276
Planned (sponsor's estimate)
Start
Oct 21, 2025
Primary completion
Dec 31, 2030
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Biosense Webster, Inc.Public (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 12, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Conditions
- Atrial Fibrillation
Interventions
Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE GeneratorDevice
Pulsed field ablation by VARIPULSE catheter with TRUPULSE generator will be used.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurences of Early Onset Primary Adverse Events (PAEs) Within 7 days of the Index Ablation ProcedureTime frame: Within 7 days post index procedure
- Freedom From Documented (Symptomatic and Asymptomatic) Atrial Tachyarrhythmias EpisodesTime frame: Day 61-1095 post-index procedure
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Cardiovascular Research Group
Phoenix, Arizona · Recruiting
Tucson Medical Center Pima Heart and Vascular
Tucson, Arizona · Recruiting
OC Memorial
Fountain Valley, California · Recruiting
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.